Tefor

Tefor may be available in the countries listed below.

Ingredient matches for Tefor

Levothyroxine

Levothyroxine sodium salt (a derivative of Levothyroxine) is reported as an ingredient of Tefor in the following countries:

• Turkey

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Tefor in the following countries:

• Serbia

International Drug Name Search

Prostamid

Prostamid may be available in the countries listed below.

Ingredient matches for Prostamid

Flutamide

Flutamide is reported as an ingredient of Prostamid in the following countries:

• India

International Drug Name Search

Dispatim

Dispatim may be available in the countries listed below.

Ingredient matches for Dispatim

Timolol

Timolol is reported as an ingredient of Dispatim in the following countries:

• Luxembourg

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Dispatim in the following countries:

• Austria


• Germany


• Luxembourg

International Drug Name Search

Scholl Verruca Removal System

Scholl Verruca Removal System may be available in the countries listed below.

Ingredient matches for Scholl Verruca Removal System

Salicylic Acid

Salicylic Acid is reported as an ingredient of Scholl Verruca Removal System in the following countries:

• Malta

International Drug Name Search

Félitussyl

Félitussyl may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Félitussyl

Butopiprine

Butopiprine hydrobromide (a derivative of Butopiprine) is reported as an ingredient of Félitussyl in the following countries:

• France

International Drug Name Search

OnabotulinumtoxinA

Pronunciation: OH-na-BOT-ue-li-num-TOX-in-A
Generic Name: OnabotulinumtoxinA
Brand Name: Botox Cosmetic

OnabotulinumtoxinA may spread from the injection site to other areas of the body, causing symptoms of a serious condition called botulism. These symptoms may occur hours to weeks after you receive OnabotulinumtoxinA. Symptoms may include loss of strength; muscle weakness; double or blurred vision; drooping eyelids; hoarseness; change or loss of voice; loss of bladder control; or trouble speaking, breathing, or swallowing. The risk may be greater in children being treated for spasticity (muscle spasms), but these symptoms may also occur in adults. OnabotulinumtoxinA is not approved for use in children. Contact your doctor immediately if these symptoms occur.

Severe and sometimes fatal breathing or swallowing problems have been reported. The risk may be greater in patients who already have breathing or swallowing problems. Tell your doctor if you have or are at risk of developing breathing or swallowing problems.

OnabotulinumtoxinA is used for:

Temporarily improving the appearance of moderate to severe lines between the eyebrows in patients 65 years old or younger. It may also be used for other conditions as determined by your doctor.

OnabotulinumtoxinA is a neurotoxin. It works by blocking nerve impulses to the muscles or sweat glands, temporarily paralyzing the muscle or gland.

Do NOT use OnabotulinumtoxinA if:

• you are allergic to any ingredient in OnabotulinumtoxinA or another botulinum product


• you have an infection at the injection site


• you are pregnant

Contact your doctor or health care provider right away if any of these apply to you.

Before using OnabotulinumtoxinA:

Some medical conditions may interact with OnabotulinumtoxinA. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have nerve problems or disease (eg, amyotrophic lateral sclerosis, motor neuropathy), muscle problems or disease (eg, Lambert-Eaton syndrome, myasthenia gravis), bleeding disorders, seizures, or severe weakness or wasting of the muscles at the injection site (eg, trouble raising your eyebrows, drooping eyelids)


• if you have a history of heart problems (eg, irregular heartbeat, a recent heart attack), swallowing or breathing problems (eg, asthma), or eye problems (eg, glaucoma, drooping eyelid)


• if you have a skin infection; or inflammation, scarring, or other skin disorders at the injection site


• if you plan to have surgery, especially surgery on your face, or if you have received OnabotulinumtoxinA or any other botulinum toxin within the past 4 months


• if you have weakness in your forehead muscles, have had any change in the way your face normally looks, or you have had surgery on your face


• if you are taking an allergy or cold medicine

Some MEDICINES MAY INTERACT with OnabotulinumtoxinA. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Aminoglycoside antibiotics (eg, gentamicin), anticholinesterase medicines (eg, neostigmine), lincosamides (eg, clindamycin), magnesium, muscle relaxants (eg, cyclobenzaprine), neuromuscular blockers (eg, atracurium), polymyxin, quinidine, or sleep medicines (eg, zolpidem) because they may increase the risk of OnabotulinumtoxinA's side effects


• Anticoagulants (eg, warfarin) because the risk of bleeding at the injection site may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if OnabotulinumtoxinA may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use OnabotulinumtoxinA:

Use OnabotulinumtoxinA as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• OnabotulinumtoxinA comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get OnabotulinumtoxinA refilled.


• OnabotulinumtoxinA is usually given as an injection at your doctor's office, hospital, or clinic.


• If you miss a dose of OnabotulinumtoxinA, contact your doctor right away.

Ask your health care provider any questions you may have about how to use OnabotulinumtoxinA.

Important safety information:

• OnabotulinumtoxinA may cause dizziness, drowsiness, loss of strength, weakness, blurred vision, or drooping eyelids. These effects may be worse if you take it with alcohol or certain medicines. Use OnabotulinumtoxinA with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do NOT use more than the recommended dose or use OnabotulinumtoxinA more often than every 3 months without checking with your doctor.


• Tell your doctor or dentist that you take OnabotulinumtoxinA before you receive any medical or dental care, emergency care, or surgery.


• Do not switch brands of OnabotulinumtoxinA. Contact your doctor if you have any questions.


• OnabotulinumtoxinA contains albumin, which comes from human blood. There is a very rare risk of getting a viral disease or a central nervous system disease called Creutzfeldt-Jakob disease from products with albumin. No cases of these problems have been found in patients who have used OnabotulinumtoxinA.


• OnabotulinumtoxinA should not be used in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Do not use OnabotulinumtoxinA if you are pregnant. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using OnabotulinumtoxinA while you are pregnant. It is not known if OnabotulinumtoxinA is found in breast milk. If you are or will be breast-feeding while you use OnabotulinumtoxinA, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of OnabotulinumtoxinA:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Anxiety; back pain; dizziness; drowsiness; dry mouth; dry or irritated eyes; facial pain; flu-like symptoms; headache; inability to focus eyes; increased cough; indigestion; nausea; neck pain; pain, redness, swelling, or tenderness at the injection site; runny nose; sensitivity to light; stiff or weak muscles at or near the injection site; sweating.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bleeding at the injection site; chest pain; difficulty swallowing or breathing; double or blurred vision or other vision changes; drooping of the upper eyelid; eyelid swelling; fainting; fever, chills, or persistent sore throat; irregular heartbeat; loss of bladder control; loss of strength; paralysis; seizures; severe or persistent muscle weakness or dizziness; shortness of breath; speech changes or problems.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: OnabotulinumtoxinA side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include paralysis; severe muscle weakness; trouble swallowing; weak or shallow breathing.

Proper storage of OnabotulinumtoxinA:

OnabotulinumtoxinA is usually handled and stored by a health care provider. If you are using OnabotulinumtoxinA at home, store OnabotulinumtoxinA as directed by your pharmacist or health care provider. Keep OnabotulinumtoxinA out of the reach of children and away from pets.

General information:

• If you have any questions about OnabotulinumtoxinA, please talk with your doctor, pharmacist, or other health care provider.


• OnabotulinumtoxinA is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about OnabotulinumtoxinA. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More OnabotulinumtoxinA resources

• OnabotulinumtoxinA Side Effects (in more detail)
• OnabotulinumtoxinA Use in Pregnancy & Breastfeeding
• OnabotulinumtoxinA Drug Interactions
• OnabotulinumtoxinA Support Group
• 18 Reviews for OnabotulinumtoxinA - Add your own review/rating

Compare OnabotulinumtoxinA with other medications

• Blepharospasm
• Cervical Dystonia
• Dystonia
• Facial Wrinkles
• Hyperhidrosis
• Migraine Prevention
• Overactive Bladder
• Spasticity
• Strabismus
• Upper Limb Spasticity
• Urinary Incontinence

Colspi

Colspi may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Colspi

Colistin Sulfate

Colistin sulfate (a derivative of Colistin) is reported as an ingredient of Colspi in the following countries:

• France

Spiramycin

Spiramycin is reported as an ingredient of Colspi in the following countries:

• France

International Drug Name Search

Neocaina

Neocaina may be available in the countries listed below.

Ingredient matches for Neocaina

Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Neocaina in the following countries:

• Peru

International Drug Name Search

Tétracycline Coophavet

Tétracycline Coophavet may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Tétracycline Coophavet

Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Tétracycline Coophavet in the following countries:

• France

International Drug Name Search

Trena

Trena may be available in the countries listed below.

Ingredient matches for Trena

Tretinoin

Tretinoin is reported as an ingredient of Trena in the following countries:

• Bangladesh

International Drug Name Search

Vitamina C Vita Orale

Vitamina C Vita Orale may be available in the countries listed below.

Ingredient matches for Vitamina C Vita Orale

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vitamina C Vita Orale in the following countries:

• Italy

International Drug Name Search

Ampicillin Trihydrous

Ampicillin Trihydrous may be available in the countries listed below.

Ingredient matches for Ampicillin Trihydrous

Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Ampicillin Trihydrous in the following countries:

• Georgia

International Drug Name Search

Fluoxétine Mylan

Fluoxétine Mylan may be available in the countries listed below.

Ingredient matches for Fluoxétine Mylan

Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxétine Mylan in the following countries:

• France

International Drug Name Search